Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2011

Nov 15, 2011

30071_dirs_2011-11-15_cfed8e97-4695-40d0-8d05-f518a8131819.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2011-11-11

Reporting Person: Douglas Robert Andrew (COO ResMed Inc.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-11-11 ResMed Common Stock M 10000 $18.67 Acquired 88404.637 Direct
2011-11-11 ResMed Common Stock S 10000 $28.202 Disposed 78404.637 Direct
2011-11-11 ResMed Common Stock M 10000 $19.250 Acquired 88404.637 Direct
2011-11-11 ResMed Common Stock S 10000 $28.201 Disposed 78404.637 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-11-11 ResMed Common Stock Options $18.670 M 10000 Disposed 2015-08-01 ResMed Common Stock (10000) Direct
2011-11-11 ResMed Common Stock Options $19.25 M 10000 Disposed 2016-02-03 ResMed Common Stock (10000) Direct

Footnotes

F1: Represents date options first became exercisable.

F2: Includes276.074 shares purchased on October 31, 2011, pursuant to ResMed's Employee Stock Purchase Plan.

F3: This transaction was executed in multiple trades at prices ranging from $28.19 to $28.22. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.